Skip to main content

Table 3 Adverse reactions

From: A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

Grades of Adverse Reactions

G1

G2

G3

G4

Total (Incidence %)

 Neutropenia

0

1

0

0

1.8

 Anemia

0

0

0

0

0

 Elevation of AST or ALT

0

1

4

0

9.1

 Elevation of creatinine

1

0

0

0

1.8

 Hyper bilirubinemia

0

0

1

0

1.8

 Anorexia

0

5

1

0

10.9

 Nausea

2

2

1

0

9.1

 Diarrhea

2

2

0

0

7.3

 Malaise

0

1

1

0

3.6

 Skin disorder

0

2

0

0

3.6

 Pneumonia

0

1

0

0

1.8

 Weight loss

0

0

1

0

1.8

 Others

1

1

0

0

3.6